AI at the Bedside: Who Is Accountable When the Algorithm Makes the Call?
About the session
There are not enough health workers.
And in many of the places where shortages are most acute, the people delivering frontline care are being asked to make difficult clinical decisions with limited training, limited supplies, and very little real-time support.
AI-enabled clinical decision support could change that.
Well-designed tools can put evidence-based guidance into the hands of frontline health workers at the point of care, support triage and maternal and child health decisions, connect remote communities with clinical oversight, and help constrained health systems extend the capabilities of the workforce they already have.
But demonstrating that a tool works is only the beginning.
The harder question is whether the health system will keep it.
Moving from a successful pilot to durable integration within a government health system is a fundamentally different challenge from building the technology.
Health ministries need evidence they trust. Tools need to fit into existing workflows, training systems, data architecture, procurement processes, and accountability structures. Governments need financing models that do not leave them responsible for infrastructure they cannot afford once external funding disappears.
And when AI is informing clinical decisions, responsibility cannot be an afterthought.
What happens when a tool makes the wrong recommendation? How should a frontline worker decide when to trust or override it? What level of human oversight is realistic in a setting where qualified clinicians are already scarce? And who is accountable when the technology becomes embedded in routine care?
These questions matter because global health has seen this pattern before.
A digital tool demonstrates promising results. A donor funds a pilot. Usage grows. Then the grant ends before government financing, ownership, procurement, or integration is in place.
The technology disappears.
Communities lose a service they had begun to rely on, and health ministries become understandably skeptical of the next externally funded technology initiative promising transformation.
AI could repeat that cycle at much greater scale.
Or it could force us to finally solve it.
This session will examine what distinguishes AI-enabled health tools that become part of public health infrastructure from those that remain trapped in perpetual pilot.
What evidence do governments actually need? Who pays after philanthropy leaves? When should government ownership begin? How should technology organizations design for integration from day one? And what does responsible AI look like when the person using it may be hours away from the clinician who could verify its recommendation?
Discussion Group Leaders
Ahson Rabbani is CEO at ChildLife Foundation, transforming pediatric emergency care in Pakistan through government partnerships, technology, AI, and telemedicine that strengthen health systems and expand access to quality care.
Mathilde Forslund is CEO at Transform Health, advancing equitable digital transformation of health systems to improve access, quality, and health outcomes globally.
Chris Marr is CEO at ThinkMD, expanding access to quality primary healthcare by equipping frontline health workers with intelligent, evidence-based clinical decision support tools.
What to expect
A practitioner conversation grounded in experience deploying AI-enabled clinical decision support, telemedicine, and other digital health tools within public health systems across Africa and South Asia, including Pakistan.
Participants will examine cases where government integration has progressed and cases where it has stalled, looking beyond the technology itself to the institutional conditions that determine whether adoption lasts.
The conversation will connect people who often approach the problem from different directions: technology developers, government health-system leaders, frontline health practitioners, funders, and responsible AI specialists.
The goal is to get practical about what each needs from the others if AI is to become durable primary healthcare infrastructure rather than another generation of promising pilots.
Who this is for
This session is for digital health innovators, health ministry officials and public health-system leaders, global health funders and investors, community health worker program managers, responsible AI practitioners, and anyone working at the intersection of technology and primary healthcare who wants a more rigorous conversation about what scale actually requires.
What you will get out of it
A framework for understanding what distinguishes AI-enabled clinical tools that become government infrastructure from those that remain pilots
Ground-level experience from clinical decision support, telemedicine, and digital health deployments within public health systems
Practical perspectives on the evidence, financing, procurement, integration, and government ownership required beyond the grant cycle
A sharper understanding of responsible AI when frontline health workers have limited ability to verify or override automated recommendations
Connections between technology developers, government health practitioners, funders, and responsible AI specialists who need to solve the scale problem together